Faculty Opinions recommendation of Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.

Ventricular Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Dose Ranging ◽

Faculty Opinions recommendation of Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020475.793502539 ◽

2014 ◽

Author(s):

Jean-Luc Vachiery

Keyword(s):

Pulmonary Hypertension ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Dose Ranging ◽

Faculty of 1000 evaluation for Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718020475.793481536 ◽

2013 ◽

Author(s):

Ioana Preston ◽

Nadine Al-Naamani

Keyword(s):

Pulmonary Hypertension ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Dose Ranging ◽

Faculty of 1000 evaluation for Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718020475.793483490 ◽

2013 ◽

Author(s):

Stephen C Mathai

Keyword(s):

Pulmonary Hypertension ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Dose Ranging ◽

Preoperative Pulmonary Hypertension Is Associated with Postoperative Left Ventricular Dysfunction in Chronic Organic Mitral Regurgitation: An Echocardiographic and Hemodynamic Study

Journal of the American Society of Echocardiography ◽

10.1016/j.echo.2006.03.016 ◽

2006 ◽

Vol 19 (8) ◽

pp. 1051-1055 ◽

Cited By ~ 18

Author(s):

Hua Yang ◽

William R. Davidson ◽

Charles E. Chambers ◽

Walter E. Pae ◽

Benjamin Sun ◽

...

Keyword(s):

Pulmonary Hypertension ◽

Mitral Regurgitation ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

590 Right ventricular dysfunction and pulmonary hypertension are independent prognostic predictors of survival in left ventricular dysfunction regardless of ischemic etiology

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(06)80387-5 ◽

2006 ◽

Vol 5 (1) ◽

pp. 135-135

Author(s):

L LAVECCHIA ◽

L VAROTTO ◽

G SPADARO ◽

C BONANNO ◽

P VINCENZI ◽

...

Keyword(s):

Pulmonary Hypertension ◽

Right Ventricular ◽

Ventricular Dysfunction ◽

Right Ventricular Dysfunction ◽

Left Ventricular ◽

Prognostic Predictors

742 Systolic septal flattening as a sign of pulmonary hypertension varies with left ventricular dysfunction: A study in ventricular interaction

European Journal of Echocardiography ◽

10.1016/s1525-2167(06)60465-4 ◽

2006 ◽

Vol 7 ◽

pp. S124-S124

Author(s):

M VATURI ◽

M HANDSCHUMACHER ◽

A SAGIE ◽

R LEVINE

Keyword(s):

Pulmonary Hypertension ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Ventricular Interaction

Evidence Of Rho-kinase Inhibitor As A Therapeutic Target For The Prevention Of Pulmonary Hypertension Secondary To Left Ventricular Dysfunction

10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6313 ◽

2010 ◽

Author(s):

ZEN-KONG DAI ◽

MING-SHIN TAN ◽

JIUNN-REN WU ◽

SHAH-HWA CHOU

Keyword(s):

Pulmonary Hypertension ◽

Therapeutic Target ◽

Ventricular Dysfunction ◽

Kinase Inhibitor ◽

Rho Kinase ◽

Left Ventricular ◽

Rho Kinase Inhibitor

Left Ventricular Dysfunction With Pulmonary Hypertension

Circulation Heart Failure ◽

10.1161/circheartfailure.112.000096 ◽

2013 ◽

Vol 6 (3) ◽

pp. 584-593 ◽

Cited By ~ 23

Author(s):

Andreas P. Kalogeropoulos ◽

Vasiliki V. Georgiopoulou ◽

Barry A. Borlaug ◽

Mihai Gheorghiade ◽

Javed Butler

Keyword(s):

Pulmonary Hypertension ◽

Ventricular Dysfunction ◽

Left Ventricular

Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction

Journal of Cardiothoracic and Vascular Anesthesia ◽

10.1053/j.jvca.2016.01.015 ◽

2016 ◽

Vol 30 (3) ◽

pp. 639-646 ◽

Cited By ~ 19

Author(s):

Abhi Mishra ◽

Bhupesh Kumar ◽

Vikas Dutta ◽

V.K. Arya ◽

Anand Kumar Mishra

Keyword(s):

Pulmonary Hypertension ◽

Cardiac Surgery ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Comparative Effect

Pulmonary hypertension, left ventricular dysfunction and plasma serotonin: commentary on Deuchar et al .

British Journal of Pharmacology ◽

10.1038/sj.bjp.0704947 ◽

2002 ◽

Vol 137 (6) ◽

pp. 937-938 ◽

Cited By ~ 2

Author(s):

Fuad Lechin ◽

Bertha van Der Dijs ◽

Alex E Lechin

Keyword(s):

Pulmonary Hypertension ◽

Ventricular Dysfunction ◽

Left Ventricular ◽

Plasma Serotonin